Culion Foundation, Inc. was awarded second place in the 2022 Gelia Castillo Award for Research on Social Innovations in Health (GCARSIH) of the Philippine Council for Health Research and Development under the Department of Science and Technology for its Culion Health project led by Dr. JR Ong.
The innovation encourages private hospitals to participate in the National TB Control Program by helping them hurdle the constraints they face, particularly equipment, personnel and recording, through the outsourced Culion Health TB clinics. This frees them from additional capital and overhead expenses. At the same time, they maximize use of their facilities, such as x-rays and laboratories. On the part of patients, they get their desired “private clinic” quality of care in a private hospital setting at public health-facility cost. This is a win-win situation for patient, hospital, and the National TB program. The innovation also encourages private practitioners to be engaged in the country's TB control program, by making their participation through referral as easy and convenient as possible.
In just one year of demonstration of innovation, Culion Health clinics became the top TB clinics contributing to case notification in Calapan, Pagadian, and Zamboanga, even if solely relying on private sector referrals. The project is now undergoing transformation to a social enterprise to further demonstrate viability and scalability of the innovation.
The GCARSIH aims to recognize the outstanding social innovations that address persistent, societal and health systems challenges. Through the innovators’ experience, we can better understand why and how social innovations create impact, and discover the keys to scale up or integrate these effective interventions into the larger health system.
Culion Foundation thanks Stop TB for supporting this prototyping project.